Rep. Waxman leak unlikely to suppress off-label guidance
Marc Iskowitz
January 01 2008
The chairman of the House Committee on Oversight and Government Reform provoked industry exponents last month by leaking FDA draft ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.